PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • IOLs • Glaucoma implants • Corneal implants • Ocular prostheses • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Custom-made ocular prostheses • Increasing preference for ASCs over hospitals for ophthalmology procedures • Increasing medical tourism for cataract surgery PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Carl Zeiss Meditec • Johnson & Johnson • MORCHER • NIDEK • Novartis • Valeant Pharmaceuticals PART 15: APPENDIX • List of abbreviations Exhibit 01: Global ophthalmology devices market Exhibit 02: Global ophthalmology devices market – Segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global ocular implants market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global ocular implants market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global ocular implants market by product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global IOLs market – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global IOLs market – Year-over-year growth 2018-2022 (%) Exhibit 22: Global glaucoma implants market – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global glaucoma implants market – Year-over-year growth 2018-2022 (%) Exhibit 24: Global corneal implants market – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Global corneal implants market – Year-over-year growth 2018-2022 (%) Exhibit 26: Global ocular prostheses market – Market size and forecast 2017-2022 ($ mn) Exhibit 27: Global ocular prostheses market – Year-over-year growth 2018-2022 (%) Exhibit 28: Market opportunity by product Exhibit 29: Customer landscape Exhibit 30: Global ocular implants market share by geography 2017-2022 (%) Exhibit 31: Global ocular implants market – Regional comparison Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 33: Americas – Year-over-year growth 2018-2022 (%) Exhibit 34: Top 3 countries in Americas Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 37: Top 3 countries in EMEA Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 39: APAC – Year-over-year growth 2018-2022 (%) Exhibit 40: Top 3 countries in APAC Exhibit 41: Market opportunity Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Carl Zeiss Meditec – Overview Exhibit 48: Carl Zeiss Meditec – Business segments Exhibit 49: Carl Zeiss Meditec – Organizational developments Exhibit 50: Carl Zeiss Meditec – Geographic focus Exhibit 51: Carl Zeiss Meditec – Segment focus Exhibit 52: Carl Zeiss Meditec – Key offerings Exhibit 53: Carl Zeiss Meditec – Key customers Exhibit 54: Johnson & Johnson – Overview Exhibit 55: Johnson & Johnson – Business segments Exhibit 56: Johnson & Johnson – Organizational developments Exhibit 57: Johnson & Johnson – Geographic focus Exhibit 58: Johnson & Johnson – Segment focus Exhibit 59: Johnson & Johnson – Key offerings Exhibit 60: Johnson & Johnson – Key customers Exhibit 61: MORCHER – Overview Exhibit 62: MORCHER – Product segments Exhibit 63: MORCHER – Organizational developments Exhibit 64: MORCHER – Geographic focus Exhibit 65: MORCHER – Product segment focus Exhibit 66: MORCHER – Key offerings Exhibit 67: MORCHER – Key customers Exhibit 68: NIDEK – Overview Exhibit 69: NIDEK – Product segments Exhibit 70: NIDEK – Organizational developments Exhibit 71: NIDEK – Geographic focus Exhibit 72: NIDEK – Product segment focus Exhibit 73: NIDEK – Key offerings Exhibit 74: NIDEK – Key customers Exhibit 75: Novartis – Overview Exhibit 76: Novartis – Business segments Exhibit 77: Novartis – Organizational developments Exhibit 78: Novartis – Geographic focus Exhibit 79: Novartis – Segment focus Exhibit 80: Novartis – Key offerings Exhibit 81: Novartis – Key customers Exhibit 82: Valeant Pharmaceuticals – Overview Exhibit 83: Valeant Pharmaceuticals – Business segments Exhibit 84: Valeant Pharmaceuticals – Organizational developments Exhibit 85: Valeant Pharmaceuticals – Geographic focus Exhibit 86: Valeant Pharmaceuticals – Segment focus Exhibit 87: Valeant – Key offerings Exhibit 88: Valeant Pharmaceuticals – Key customers

Carl Zeiss Meditec Johnson & Johnson MORCHER NIDEK Novartis Valeant Pharmaceuticals